A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma

A Ten-N6-Methyladenosine (m6A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma

ObjectivesThe study aims to analyze the expression of N6-methyladenosine (m6A)-modified genes in rectum adenocarcinoma (READ) and identify reliable prognostic biomarkers to predict the prognosis of READ.Materials and MethodsRNA sequence data of READ and corresponding clinical survival data were obta...

Full description

Bibliographic Details
Main Authors: Wei Huang, Gen Li, Zihang Wang, Lin Zhou, Xin Yin, Tianshu Yang, Pei Wang, Xu Teng, Yajuan Feng, Hefen Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
m6A
risk score
prognostic prediction
READ
gene signature
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.567931/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.567931/full

Similar Items